- 5 -
2 29 12 6 ()
Session 9:0010:20
17.
1,2, Tirsa LE van Westering2, Henrik J Johansson3, 1, 1, Janne
Lehtiö3, 4,
Matthew JA Wood2, Thomas C Roberts2,5, 1
1Dept of Molecular Therapy, National Center of Neurology and
Psychiatry (NCNP), Japan, 2 Dept of Physiology,
Anatomy and Genetics, University of Oxford, UK, 3 Dept of
Oncology/Pathology, Cancer proteomics Mass Spectr
ometry, Karolinska Institutet, Sweden, 4 Dept of Medical Genetics,
School of Human Development, University of
Alberta, Canada, 5 Sanford Burnham Prebys Medical Discovery
Institute, USA
18.
2’- 1, 1, 2, 2, 2, 2, 2, 3
4, 5
1 , 2, 3 , 4
, 5
19. ENA DS-5141b 1, 2
1 , 2 LCM 2G
20. FSHD)
1, Ashley Guncay1, Kenji RQ Lim1, 1, Yi-Wen Chen2
1 University of Alberta, Faculty of Medicine and Dentistry, 2
Children’s National Health Systems (Washington DC)
- 6 -
DMD 1, Emma Tabe Eko Niba2
1 , 2
Session 2 10:3011:30
22. Integration of biomarkers into clinical trials for DMD
Eric Hoffman Binghamton University
11:3012:45
Session 12:4513:30 23. DMD
AAV DMD 1,2, 1,2,3, 1,2,3, 3, 2,3, 4, 4, 3
1 , 2 , 3
, 4 JCR
24.